Stocks
Aravive, Inc.ARAV
NASDAQHealthcareBiotechnology$0.04-13.39%
Focused on developing innovative therapies for life-threatening diseases, this biopharmaceutical company specializes in oncology and fibrosis treatments. Investors monitor its clinical-stage pipeline and potential for FDA approvals given its micro-cap status and high-risk, high-reward profile.
Market Cap: $2.9M52W Range: $0.04 – $2.46
Congressional Interest in Aravive, Inc. (ARAV)
1 member of Congress has disclosed 1 trade in Aravive, Inc. (ARAV), a Healthcare company. The buy/sell breakdown shows 0 purchases versus 1 sale, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
1
Unique Politicians
1
Buys
0
Sells
1
Who in Congress Is Trading ARAV?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2018-12-28 | BOB GIBBS | sell | $158+ |